A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemo With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas

NCT01240304 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped no subjects enrolled

Conditions

Pancreatic Cancer

Interventions

DRUG: Gemcitabine
RADIATION: Radiation therapy
PROCEDURE: pancreaticoduodenectomy

Sponsor

University of Arkansas